EVGN
Price
$1.35
Change
-$0.01 (-0.74%)
Updated
Aug 15 closing price
Capitalization
11.36M
3 days until earnings call
PMVP
Price
$1.52
Change
-$0.03 (-1.94%)
Updated
Aug 15 closing price
Capitalization
80.55M
82 days until earnings call
Interact to see
Advertisement

EVGN vs PMVP

Header iconEVGN vs PMVP Comparison
Open Charts EVGN vs PMVPBanner chart's image
Evogene
Price$1.35
Change-$0.01 (-0.74%)
Volume$39.44K
Capitalization11.36M
PMV Pharmaceuticals
Price$1.52
Change-$0.03 (-1.94%)
Volume$256.11K
Capitalization80.55M
EVGN vs PMVP Comparison Chart in %
Loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVGN vs. PMVP commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (EVGN: $1.35 vs. PMVP: $1.52)
Brand notoriety: EVGN and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 15% vs. PMVP: 99%
Market capitalization -- EVGN: $11.36M vs. PMVP: $80.55M
EVGN [@Biotechnology] is valued at $11.36M. PMVP’s [@Biotechnology] market capitalization is $80.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • EVGN’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than EVGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 3 bullish TA indicator(s).

  • EVGN’s TA Score: 5 bullish, 4 bearish.
  • PMVP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EVGN is a better buy in the short-term than PMVP.

Price Growth

EVGN (@Biotechnology) experienced а +11.57% price change this week, while PMVP (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

EVGN is expected to report earnings on Aug 19, 2025.

PMVP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($80.5M) has a higher market cap than EVGN($11.4M). PMVP YTD gains are higher at: 0.662 vs. EVGN (-27.807). EVGN has higher annual earnings (EBITDA): -14.42M vs. PMVP (-87.97M). PMVP has more cash in the bank: 160M vs. EVGN (9.85M). PMVP has less debt than EVGN: PMVP (1.11M) vs EVGN (13M). EVGN has higher revenues than PMVP: EVGN (6.77M) vs PMVP (0).
EVGNPMVPEVGN / PMVP
Capitalization11.4M80.5M14%
EBITDA-14.42M-87.97M16%
Gain YTD-27.8070.662-4,199%
P/E Ratio0.30N/A-
Revenue6.77M0-
Total Cash9.85M160M6%
Total Debt13M1.11M1,175%
FUNDAMENTALS RATINGS
EVGN: Fundamental Ratings
EVGN
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVGNPMVP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNSE8.681.18
+15.73%
Sensei Biotherapeutics Inc
SEZL91.870.40
+0.44%
Sezzle Inc
ABUS3.37-0.01
-0.15%
Arbutus Biopharma Corp
FIX680.86-9.00
-1.30%
Comfort Systems USA
MMLP3.41-0.07
-2.01%
Martin Midstream Partners LP

EVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVGN has been loosely correlated with CARM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if EVGN jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
-0.74%
CARM - EVGN
61%
Loosely correlated
+2.35%
INSM - EVGN
34%
Loosely correlated
+0.04%
AXON - EVGN
30%
Poorly correlated
+0.59%
PMVP - EVGN
29%
Poorly correlated
-1.94%
ARRY - EVGN
28%
Poorly correlated
+25.33%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-1.94%
CLLS - PMVP
39%
Loosely correlated
-0.35%
MTVA - PMVP
35%
Loosely correlated
N/A
CMVLF - PMVP
34%
Loosely correlated
N/A
IDYA - PMVP
34%
Loosely correlated
-0.16%
LXEO - PMVP
34%
Loosely correlated
-1.46%
More